Your browser doesn't support javascript.
loading
A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients.
Hammer, Fabian; Malzahn, Uwe; Donhauser, Julian; Betz, Christoph; Schneider, Markus P; Grupp, Clemens; Pollak, Nils; Störk, Stefan; Wanner, Christoph; Krane, Vera.
Afiliación
  • Hammer F; Department of Medicine I, Division of Cardiology, University Hospital Würzburg, Würzburg, Germany; Comprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany; Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany. Electronic ad
  • Malzahn U; Clinical Trial Center, University Hospital Würzburg, Würzburg, Germany.
  • Donhauser J; Department of Diagnostic and Interventional Radiology, University of Würzburg, Würzburg, Germany.
  • Betz C; Medical Clinic III, Department of Nephrology, University Hospital Frankfurt, Frankfurt, Germany.
  • Schneider MP; Department of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, Germany.
  • Grupp C; Department of Nephrology and Hypertension, Sozialstiftung Bamberg, Bamberg, Germany.
  • Pollak N; Department of Pharmacy, University Hospital Würzburg, Würzburg, Germany.
  • Störk S; Department of Medicine I, Division of Cardiology, University Hospital Würzburg, Würzburg, Germany; Comprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany.
  • Wanner C; Comprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany; Department of Medicine I, Division of Nephrology, University Hospital Würzburg, Würzburg, Germany.
  • Krane V; Comprehensive Heart Failure Center, University and University Hospital Würzburg, Würzburg, Germany; Department of Medicine I, Division of Nephrology, University Hospital Würzburg, Würzburg, Germany.
Kidney Int ; 95(4): 983-991, 2019 04.
Article en En | MEDLINE | ID: mdl-30712923

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Espironolactona / Remodelación Ventricular / Antagonistas de Receptores de Mineralocorticoides / Insuficiencia Cardíaca / Ventrículos Cardíacos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Kidney Int Año: 2019 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Espironolactona / Remodelación Ventricular / Antagonistas de Receptores de Mineralocorticoides / Insuficiencia Cardíaca / Ventrículos Cardíacos Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Kidney Int Año: 2019 Tipo del documento: Article